40% OFF Limited-Time Offer Retatrutide 60 mg Injectable

[Anabolix]

40% OFF Limited-Time Offer Retatrutide 60 mg Injectable​

Retatrutide is an investigational triple receptor agonist targeting GIP, GLP-1 and glucagon receptors, currently being evaluated in Phase 3 clinical trials. Recent clinical data have reported meaningful changes in body weight and glycemic measures, making retatrutide an important area of ongoing metabolic research. (Eli Lilly and Company)

Order Now​

LIMITED-TIME OFFER: 40% OFF
For those following the latest developments in metabolic research, this is an opportunity to explore the topic and product information while the promotional offer is available.

Stock Status​

Product: Retatrutide 60mg Pen
Availability: In Stock
Stock Level: Limited Stock
Availability: While current supply lasts

If you are interested in Retatrutide 60mg Pen, check the current stock status before ordering because the available quantity is limited and may change without notice.

What Is Retatrutide?​

Retatrutide (LY3437943) is an investigational compound being studied for its activity on three metabolic hormone receptors:

• GLP-1
• GIP
• Glucagon

Its unique triple-receptor mechanism has generated significant interest in ongoing metabolic and obesity research.

What Does “60 mg Pen” Mean?​

The 60 mg figure refers to the total amount represented by a particular product/pen presentation. It should not automatically be interpreted as a single dose.

Clinical-trial dosing of retatrutide has involved different dose levels and study protocols. The appropriate dose and escalation schedule depend on the clinical protocol being used and should not be assumed from the total amount printed on a product.

Note:Retatrutide is investigational. Consult a qualified healthcare professional before considering its use.